NxStage Medical, Inc. 4
4 · NxStage Medical, Inc. · Filed Dec 16, 2014
Insider Transaction Report
Form 4
Hershberger Kevin
Chief Accounting Officer
Transactions
- Exercise/Conversion
Common Stock
2014-12-12$9.96/sh+5,000$49,800→ 26,485 total - Sale
Common Stock
2014-12-15$17.45/sh−3,000$52,350→ 18,485 total - Sale
Common Stock
2014-12-12$17.04/sh−5,000$85,200→ 21,485 total - Exercise/Conversion
Stock Option (Right to Buy)
2014-12-12−5,000→ 7,576 totalExercise: $9.96From: 2010-04-03Exp: 2017-03-02→ Common Stock (5,000 underlying)
Footnotes (1)
- [F1]This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 12, 2014.